tiprankstipranks
Trending News
More News >
VolitionRX (VNRX)
:VNRX
US Market
Advertisement

VolitionRX (VNRX) Stock Statistics & Valuation Metrics

Compare
500 Followers

Total Valuation

VolitionRX has a market cap or net worth of $73.77M. The enterprise value is $85.42M.
Market Cap$73.77M
Enterprise Value$85.42M

Share Statistics

VolitionRX has 107,595,420 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding107,595,420
Owned by Insiders12.26%
Owned by Institutions19.63%

Financial Efficiency

VolitionRX’s return on equity (ROE) is 1.08 and return on invested capital (ROIC) is -987.22%.
Return on Equity (ROE)1.08
Return on Assets (ROA)-2.87
Return on Invested Capital (ROIC)-987.22%
Return on Capital Employed (ROCE)-16.80
Revenue Per Employee14.51K
Profits Per Employee-320.68K
Employee Count85
Asset Turnover0.13
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of VolitionRX is ―. VolitionRX’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value-2.08
Price to FCF
Price to Operating Cash Flow-2.97
PEG Ratio

Income Statement

In the last 12 months, VolitionRX had revenue of 1.23M and earned -26.97M in profits. Earnings per share was -0.31.
Revenue1.23M
Gross Profit1.23M
Operating Income-27.02M
Pretax Income-27.26M
Net Income-26.97M
EBITDA-25.62M
Earnings Per Share (EPS)-0.31

Cash Flow

In the last 12 months, operating cash flow was -21.38M and capital expenditures -413.19K, giving a free cash flow of -21.79M billion.
Operating Cash Flow-21.38M
Free Cash Flow-21.79M
Free Cash Flow per Share-0.20

Dividends & Yields

VolitionRX pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.37
52-Week Price Change-2.86%
50-Day Moving Average0.70
200-Day Moving Average0.61
Relative Strength Index (RSI)48.10
Average Volume (3m)165.69K

Important Dates

VolitionRX upcoming earnings date is Nov 13, 2025, After Close (Confirmed).
Last Earnings DateAug 14, 2025
Next Earnings DateNov 13, 2025
Ex-Dividend Date

Financial Position

VolitionRX as a current ratio of 0.52, with Debt / Equity ratio of -26.53%
Current Ratio0.52
Quick Ratio0.52
Debt to Market Cap0.09
Net Debt to EBITDA-0.10
Interest Coverage Ratio-79.40

Taxes

In the past 12 months, VolitionRX has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

VolitionRX EV to EBITDA ratio is -2.13, with an EV/FCF ratio of -2.06.
EV to Sales44.16
EV to EBITDA-2.13
EV to Free Cash Flow-2.06
EV to Operating Cash Flow-2.10

Balance Sheet

VolitionRX has $2.26M in cash and marketable securities with $10.94M in debt, giving a net cash position of $8.69M billion.
Cash & Marketable Securities$2.26M
Total Debt$10.94M
Net Cash$8.69M
Net Cash Per Share$0.08
Tangible Book Value Per Share-$0.31

Margins

Gross margin is 100.00%, with operating margin of -2190.90%, and net profit margin of -2186.27%.
Gross Margin100.00%
Operating Margin-2190.90%
Pretax Margin-2209.79%
Net Profit Margin-2186.27%
EBITDA Margin-2076.62%
EBIT Margin-2182.20%

Analyst Forecast

The average price target for VolitionRX is $2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.00
Price Target Upside194.12% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast35.10%
EPS Growth Forecast39.15%

Scores

Smart Score8
AI Score47
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis